Jeffrey K Tobias Insider Trading
Get free email notifications about insider trading for Jeffrey K Tobias.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Jeffrey K Tobias. Jeffrey K Tobias is a Chief Medical Officer in NeurogesX Inc ($NGSX) and a CMO, EVP Research & Deve in NeurogesX Inc ($NGSX) and a EVP Research & Dev & CMO in NeurogesX Inc ($NGSX).
Address: C/O NEUROGESX, INC. 2215 BRIDGEPOINTE PARKWAY, SUITE 200 SAN MATEO 94404 CA
Companies in which Jeffrey K Tobias is an Insider
NeurogesX Inc
Trading Symbol: NGSXIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Jeffrey K Tobias: CMO, EVP Research & Deve, EVP Research & Dev & CMO, Chief Medical Officer
Holdings: 4,999 shares
Latest Transaction: Sep 20 2011
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Jeffrey K Tobias
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Sep 20 2011 | NGSX | NeurogesX Inc | Tobias Jeffrey K | CMO, EVP Research & ... | Option Exercise | A | 0.00 | 30,000 | 0 | 30,000 | |
May 19 2011 | NGSX | NeurogesX Inc | Tobias Jeffrey K | EVP Research & Dev ... | Sell | S | 2.82 | 1,115 | 3,144 | 4,999 | 6.1 K to 5 K (-18.24 %) |
May 19 2011 | NGSX | NeurogesX Inc | Tobias Jeffrey K | EVP Research & Dev ... | Sell | S | 2.73 | 1,333 | 3,639 | 6,114 | 7.4 K to 6.1 K (-17.90 %) |
May 16 2011 | NGSX | NeurogesX Inc | Tobias Jeffrey K | EVP Research & Dev ... | Sell | S | 2.84 | 1,333 | 3,786 | 7,447 | 8.8 K to 7.4 K (-15.18 %) |
May 16 2011 | NGSX | NeurogesX Inc | Tobias Jeffrey K | EVP Research & Dev ... | Sell | S | 2.81 | 733 | 2,060 | 7,447 | 8.2 K to 7.4 K (-8.96 %) |
May 16 2011 | NGSX | NeurogesX Inc | Tobias Jeffrey K | EVP Research & Dev ... | Sell | S | 2.91 | 600 | 1,746 | 8,180 | 8.8 K to 8.2 K (-6.83 %) |
Apr 29 2011 | NGSX | NeurogesX Inc | Tobias Jeffrey K | EVP Research & Dev ... | Option Exercise | A | 3.29 | 75,000 | 246,750 | 75,000 |